174 related articles for article (PubMed ID: 29866822)
21. Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland.
Tryggvason G; Hilmarsdottir B; Gunnarsson GH; Jónsson JJ; Jónasson JG; Magnússon MK
APMIS; 2010 Sep; 118(9):648-56. PubMed ID: 20718716
[TBL] [Abstract][Full Text] [Related]
22. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations.
Kang HJ; Koh KH; Yang E; You KT; Kim HJ; Paik YK; Kim H
Proteomics; 2006 Feb; 6(4):1151-7. PubMed ID: 16402362
[TBL] [Abstract][Full Text] [Related]
23. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate.
Prenen H; Cools J; Mentens N; Folens C; Sciot R; Schöffski P; Van Oosterom A; Marynen P; Debiec-Rychter M
Clin Cancer Res; 2006 Apr; 12(8):2622-7. PubMed ID: 16638875
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
26. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
27. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
[TBL] [Abstract][Full Text] [Related]
28. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
29. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].
Cao H; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336
[TBL] [Abstract][Full Text] [Related]
30. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
31. [Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].
Emile JF
Med Sci (Paris); 2013; 29(6-7):630-6. PubMed ID: 23859518
[TBL] [Abstract][Full Text] [Related]
32. Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRA.
Maier J; Lange T; Kerle I; Specht K; Bruegel M; Wickenhauser C; Jost P; Niederwieser D; Peschel C; Duyster J; von Bubnoff N
Clin Cancer Res; 2013 Sep; 19(17):4854-67. PubMed ID: 23833305
[TBL] [Abstract][Full Text] [Related]
33. Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis.
Lee JH; Kim Y; Choi JW; Kim YS
J Gastrointestin Liver Dis; 2013 Dec; 22(4):413-8. PubMed ID: 24369323
[TBL] [Abstract][Full Text] [Related]
34. Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.
Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im SA; Gupta S; Kang YK; Schöffski P; Schuette J; Soulières D; Blay JY; Goldstein D; Fly K; Huang X; Corsaro M; Lechuga MJ; Martini JF; Heinrich MC
BMC Cancer; 2016 Jan; 16():22. PubMed ID: 26772734
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal stromal tumors.
Antonescu C
Curr Top Microbiol Immunol; 2012; 355():41-57. PubMed ID: 22015552
[TBL] [Abstract][Full Text] [Related]
36. Inherited predisposition to gastrointestinal stromal tumor.
Agarwal R; Robson M
Hematol Oncol Clin North Am; 2009 Feb; 23(1):1-13, vii. PubMed ID: 19248967
[TBL] [Abstract][Full Text] [Related]
37. Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways.
Veiga I; Silva M; Vieira J; Pinto C; Pinheiro M; Torres L; Soares M; Santos L; Duarte H; Bastos AL; Coutinho C; Dinis J; Lopes C; Teixeira MR
Genes Chromosomes Cancer; 2010 Feb; 49(2):91-8. PubMed ID: 19847891
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine.
Mei L; Smith SC; Faber AC; Trent J; Grossman SR; Stratakis CA; Boikos SA
Trends Cancer; 2018 Jan; 4(1):74-91. PubMed ID: 29413424
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors.
Braggio E; Braggio Dde A; Small IA; Lopes LF; Valadão M; Gouveia ME; Moreira Ados S; Linhares E; Romano S; Bacchi CE; Renault IZ; Guimarães DP; Ferreira CG
Anticancer Res; 2010 Jun; 30(6):2407-14. PubMed ID: 20651400
[TBL] [Abstract][Full Text] [Related]
40. MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor.
Hemming ML; Benson MR; Loycano MA; Anderson JA; Andersen JL; Taddei ML; Krivtsov AV; Aubrey BJ; Cutler JA; Hatton C; Sicinska E; Armstrong SA
Cancer Discov; 2022 Jul; 12(7):1804-1823. PubMed ID: 35499757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
